Approach to a solid solitary pulmonary nodule in two different settings-"Common is common, rare is rare"

Journal of Thoracic Disease

Volumn 6, Issue 3, 2014, Pages 237-248

  Murrmann, Gabriele B ^a   Van Vollenhoven, Femke H M van ^a   Moodley, Loven ^b  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

algorithm; diagnostic work up; inflammatory lung disease; lung neoplasms; Solitary pulmonary nodule (SPN)

Indexed keywords

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUNG CANCER; LUNG NODULE; LUNG RESECTION; MEDICAL INFORMATION; NETHERLANDS; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PROBABILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TRANSTHORACIC BIOPSY;

EID: 84896028176     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2013.11.13     Document Type: Review

References (62)

1. Huber RM. Manual Tumoren der Lunge und des Mediastinum. Muenchen: W. Zuckerschwerdt Verlag, 2011.
2. World Health Organization. Available online: www.who.int, 2013.
3. Veronesi G, Maisonneuve P, De Pas TM, et al. Does lung cancer screening with low-dose CT remain promising despite disappointing DANTE results? Am J Respir Crit Care Med 2010;182:720-1; author reply 721.
4. Veronesi G, Maisonneuve P, Spaggiari L, et al. Long-term outcomes of a pilot CT screening for lung cancer. Ecancermedicalscience 2010;4:186.
5. Patel VK, Naik SK, Naidich DP, et al. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest 2013;143:825-39.
6. Tuddenham WJ. Glossar y o f terms for thoraci c radiolog y: recommendations of the Nomenclature Committee of the Fleischner Society. AJR Am J Roentgenol 1984;143:509-17.
7. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164-8.
8. Gohagan J, Marcus P, Fagerstrom R, et al. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-21.
9. Diederich S, Wormanns D, Heindel W. Radiologic screening for lung cancer: present status and future perspectives. Rofo 2001;173:873-82.
10. Ru Zhao Y, Xie X, de Koning HJ, et al. NELSON lung cancer screening study. Cancer Imaging 2011;11 Spec No A:S79-84.
11. Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidencebased clinical practice guidelines (2nd edition). Chest 2007;132:94S-107S.
12. Midthun DE. Early diagnosis of lung cancer. F1000Prime Rep 2013;5:12.
13. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164-8.
14. Tan BB, Flaherty KR, Kazerooni EA, et al. The solitary pulmonary nodule. Chest 2003;123:89S-96S.
15. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:108S-30S.
16. Jasmer RM, Edinburgh KJ, Thompson A, et al. Clinical and radiographic predictors of the etiology of pulmonary nodules in HIV-infected patients. Chest 2000;117:1023-30.
17. Schiavon F, Berletti R, Soardi GA, et al. Multidisciplinary management of the solitary pulmonary nodule (SPN): our opinion. Radiol Med 2005;110:149-55.
18. Romero Candeira S, Alemany Frances L, Martin Serrano C, et al. The solitary pulmonary nodule. An analysis of the experience over 6 years in a medical service. An Med Interna 1994;11:427-30.
19. Patel VK, Naik SK, Naidich DP, et al. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm. Chest 2013;143:840-6.
20. Alzahouri K, Velten M, Arveux P, et al. Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts. BMC Cancer 2008;8:93.
21. Dabrowska M, Kolasa A, Zukowska M, et al. Analysis of solitary pulmonary nodules found in chest radiograms. Pneumonol Alergol Pol 2009;77:37-42.
22. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910-9.
23. Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013;369:920-31.
24. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177-84.
25. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400.
26. Mehta HJ, Ravenel JG, Shaftman SR, et al. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest 2014;145:464-72.
27. Marten K, Engelke C, Seyfarth T, Grillhosl A, et al. Computer-aided detection of pulmonary nodules: influence of nodule characteristics on detection performance. Clin Radiol 2005;60:196-206.
28. Henschke CI, Yankelevitz DF, Yip R, et al. Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology 2012;263:578-83.
29. Heuvelmans MA, Oudkerk M, de Bock GH, et al. Optimisation of volumedoubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 2013;23:1836-45.
30. Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997;157:849-55.
31. Gould MK, Ananth L, Barnett PG, Veterans Affairs SNAP Cooperative Study Group. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007;131:383-8.
32. Wang Y, de Bock GH, van Klaveren RJ, et al. Volumetric measurement of pulmonary nodules at low-dose chest CT: effect of reconstruction setting on measurement variability. Eur Radiol 2010;20:1180-7.
33. Vansteenkiste JF. Imaging in lung cancer: positron emission tomography scan. Eur Respir J Suppl 2002;35:49s-60s.
34. Vansteenkiste JF, Stroobants SS. PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol 2006;1:71-3.
35. Barger RL Jr, Nandalur KR. Diagnostic performance of dual-time 18F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis. Acad Radiol 2012;19:153-8.
36. Jeong YJ, Yi CA, Lee KS. Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment. AJR Am J Roentgenol 2007;188:57-68.
37. Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285:914-24.
38. Buck AK, Herrmann K, Stargardt T, et al. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. J Nucl Med Technol 2010;38:6-17.
39. Chest-Lung-Solitary pulmonary nodule: benign versus malignant differentiation with CT and PET-CT January 2013. Radiological Society of the Netherlands. Available online: www.radiologyassistant.nl (Accessed July/29, 2013).
40. Cao JQ, Rodrigues GB, Louie AV, et al. Systematic review of the costeffectiveness of positron-emission tomography in staging of non-small-cell lung cancer and management of solitary pulmonary nodules. Clin Lung Cancer 2012;13:161-70.
41. Ost DE, Gould MK. Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med 2012;185:363-72.
42. Ray CE Jr, Mohammed TL. Review of ACR Appropriateness Criteria® Radiologic Management of Thoracic Nodules and Masses. J Thorac Imaging 2012;27:W85-6.
43. Rivera MP, Mehta AC, American College of Chest Physicians. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:131S-48S.
44. Zaman M, Bilal H, Woo CY, et al. In patients undergoing videoassisted thoracoscopic surgery excision, what is the best way to locate a subcentimetre solitary pulmonary nodule in order to achieve successful excision? Interact Cardiovasc Thorac Surg 2012;15:266-72.
45. Wender R, Fontham ET, Barrera E Jr, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-17.
46. Available online: http://www.who.int/tb/publications/2009/who_htm_ tb_2009_420_beforeprint.pdf.
47. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011;377:1495-505.
48. Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013;13:349-61.
49. Lee HY, Seong MW, Park SS, et al. Diagnostic accuracy of Xpert(R) MTB/ RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis 2013;17:917-21.
50. De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2007;32:1-8.
51. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71.
52. National Lung Screening Trial Research Team, Aberle DR, Berg CD, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-53.
53. National Lung Screening Trial Research Team, Church TR, Black WC, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013;368:1980-91.
54. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
55. Prosch H, Strasser G, Oschatz E, et al. Management of patients with small pulmonary nodules: a survey of radiologists, pulmonologists, and thoracic surgeons. AJR Am J Roentgenol 2006;187:143-8.
56. Diederich S. Lung cancer screening: status in 2007. Radiologe 2008;48:39-44.
57. Nair A, Hansell DM. European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol 2011;21:2445-54.
58. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.
59. Masciocchi M, Wagner B, Lloyd B. Quality review: Fleischner criteria adherence by radiologists in a large community hospital. J Am Coll Radiol 2012;9:336-9.
60. Guckenberger M, Allgauer M, Appold S, et al. Safety and efficacy of stereotactic body radiotherapy for stage i non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. J Thorac Oncol 2013;8:1050-8.
61. Palma D, Lagerwaard F, Rodrigues G, et al. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys 2012;82:1149-56.
62. van Klaveren RJ, Oudkerk M, Mali WP, et al. Multi-detector CT screening for lung cancer is still to be discouraged for the time being. Ned Tijdschr Geneeskd 2008;152:125-8.